Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
Radiopharm (RADX) has traded in a relatively narrow range in recent weeks, with the stock hovering near $4.73 and showing no change in the latest session. The price action remains contained between established support at $4.49 and resistance at $4.97, suggesting investors are in a wait-and-see mode
Radiopharm (RADX) at $$4.73 — Buy, Sell, or Hold? 2026-05-15 - Analyst Recommended Stocks
RADX - Stock Analysis
4481 Comments
1573 Likes
1
Romarion
Active Reader
2 hours ago
Free US stock market sentiment analysis and institutional activity tracking to understand what smart money is doing in the market. Our tools reveal buying and selling patterns of large institutional investors who often move stock prices significantly. We provide 13F filing analysis, options flow data, and sector rotation indicators for comprehensive market intelligence. Follow the money and make smarter investment decisions with our comprehensive sentiment analysis and institutional tracking tools.
👍 101
Reply
2
Paizlyn
Regular Reader
5 hours ago
Investors are weighing earnings reports against broader economic data.
👍 171
Reply
3
Jaxtin
Daily Reader
1 day ago
The market is consolidating in a controlled manner, with broad sector participation supporting current gains. Support zones are holding, suggesting limited downside risk. Traders should monitor momentum indicators for trend continuation signals.
👍 12
Reply
4
Melisha
Trusted Reader
1 day ago
Insightful and well-structured analysis.
👍 182
Reply
5
Raey
Experienced Member
2 days ago
That skill should be illegal. 😎
👍 46
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.